Patents by Inventor Guoqiang Wang

Guoqiang Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method and apparatus for content identifier based radius constrained cache flooding to enable efficient content routing
    Patent number: 8667172
    Abstract: A networking system comprising a plurality of content routers coupled to each other and to a plurality of providers and configured to route and cache content data, wherein the content routers are further configured to locate and route requested content to a user node coupled to the content routers, wherein the providers are configured to publish content and the content routers are further configured to receive and cache the content data in response to an interest request for content and to flood a content identifier for the content data to a plurality of neighboring content routers within a specified radius, wherein the content identifier enables the plurality of neighboring content routers to determine a nearest location from which to obtain the content data to enable efficient content routing.
    Type: Grant
    Filed: December 6, 2011
    Date of Patent: March 4, 2014
    Assignee: Futurewei Technologies, Inc.
    Inventors: Ravishankar Ravindran, Guoqiang Wang, Kathleen Nichols
  • Macrocyclic proline derived HCV serine protease inhibitors
    Patent number: 8648037
    Abstract: The present invention discloses compounds of Formula I or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit serine protease activity, particularly the activity of hepatitis C virus (HCV) NS3-NS4A protease. Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
    Type: Grant
    Filed: September 20, 2011
    Date of Patent: February 11, 2014
    Assignee: Enanta Pharmaceuticals, Inc.
    Inventors: Yat Sun Or, Jun Ma, Guoqiang Wang, Jiang Long, Bin Wang
  • Optimization of a Data Flow Program Based on Access Pattern Information
    Publication number: 20140040855
    Abstract: System and method for optimizing a data flow diagram based on access pattern information are described. Access pattern information for a data flow diagram may be received. The data flow diagram may include a plurality of interconnected actors, e.g., functional blocks, visually indicating functionality of the data flow diagram. The access pattern information may include one or more of: input pattern information specifying cycles on which tokens are consumed by at least one of the actors, or output pattern information specifying cycles on which tokens are produced by at least one of the actors. A program that implements the functionality of the data flow diagram may be generated based at least in part on the access pattern information.
    Type: Application
    Filed: October 9, 2013
    Publication date: February 6, 2014
    Applicant: NATIONAL INSTRUMENTS CORPORATION
    Inventors: Guoqiang Wang, Kaushik Ravindran, Rhishikesh Limaye, Guang Yang, Arkadeb Ghosal, Hugo A. Andrade, John R. Allen, Jacob Kornerup, Ian C. Wong, Jeffrey N. Correll, Michael J. Trimborn
  • Method and Device for Controlling Composite Scanning Device, and Composite Scanning System
    Publication number: 20140009779
    Abstract: The disclosure discloses a method and device for controlling a composite scanning device, and a composite scanning system. The composite scanning system includes: a composite scanning device and a host which includes: an application module configured for performing a first capability setting on the composite scanning device, obtaining the scanned image data from the composite scanning device after the first capability setting, and processing the scanned image data in a first TWAIN session state; and a configuration module configured for performing a second capability setting on the composite scanning device according to the processing result of the application module in the first TWAIN session state. By the disclosure, the efficiency of capability setting in the composite scanning system which is compatible with TWAIN protocol can be improved.
    Type: Application
    Filed: March 13, 2012
    Publication date: January 9, 2014
    Applicant: SHANDONG NEW BEIYANG INFORMATION TECHNOLOGY CO., LTD.
    Inventors: Mingxia Geng, Guoqiang Wang, Yingchan Jiang, Xiangang Zhu
  • Antiviral agents
    Patent number: 8623814
    Abstract: The present invention provides antiviral compounds of formula (I), as well as pharmaceutical compositions comprising these compounds, methods for synthesizing these compounds and methods of using these compounds for treating a viral infection.
    Type: Grant
    Filed: February 23, 2011
    Date of Patent: January 7, 2014
    Assignee: Enanta Pharmaceuticals, Inc.
    Inventors: Yat Sun Or, In Jong Kim, Guoqiang Wang, Jiang Long
  • MACROCYCLIC NUCLEOSIDE PHOSPHORAMIDATE DERIVATIVES
    Publication number: 20130315864
    Abstract: The present invention provides nucleoside phosphoramidate compounds of Formula I, where R1, R2a, R2b, R3, R4, R5a, R5b, R6, R7, R8a, R8b, M and W are as defined herein. The invention further includes pharmaceutical compositions comprising a compound of Formula I, methods of use of these compounds for treating a viral infection, and methods of producing these compounds.
    Type: Application
    Filed: May 17, 2013
    Publication date: November 28, 2013
    Applicant: ENANTA PHARMACEUTICALS, INC.
    Inventors: Yat Sun Or, Jun Ma, Guoqiang Wang
  • 2?-chloroacetylenyl substituted nucleoside derivatives
    Patent number: 8575119
    Abstract: The present invention relates to 2?-chloroacetylenyl-substituted nucleoside derivatives of the general formula (I): As well as pharmaceutical compositions comprising such compounds and methods to treat or prevent an HIV infection, HBV infection, HCV infection or abnormal cellular proliferation, comprising administering said compounds or compositions. In addition, the present invention includes processes for the preparation of such compounds, and the related ?-D and ?-L-nucleoside derivatives.
    Type: Grant
    Filed: September 21, 2012
    Date of Patent: November 5, 2013
    Assignee: Enanta Pharmaceuticals, Inc.
    Inventors: Guoqiang Wang, In Jong Kim, Yat Sun Or
  • METHOD AND SYSTEM FOR SECURE MULTIPARTY CLOUD COMPUTATION
    Publication number: 20130275752
    Abstract: One embodiment of the present invention provides a system for performing secure multiparty cloud computation. During operation, the system receives multiple encrypted datasets from multiple clients. An encrypted dataset associated with a client is encrypted from a corresponding plaintext dataset using a unique, client-specific encryption key. The system re-encrypts the multiple encrypted datasets to a target format, evaluates a function based on the re-encrypted multiple datasets to produce an evaluation outcome, and sends the evaluation outcome to the multiple clients, which are configured to cooperatively decrypt the evaluation outcome to obtain a plaintext evaluation outcome.
    Type: Application
    Filed: April 17, 2012
    Publication date: October 17, 2013
    Applicant: FUTUREWEI TECHNOLOGIES, INC.
    Inventors: Xinwen Zhang, Qingji Zheng, Antontius Kalker, Guoqiang Wang
  • Cyclosporin analogues
    Patent number: 8481483
    Abstract: The present invention provides cyclosporin analogues of formula I, and compositions comprising these compounds, as well as processes for their preparation, intermediates in their synthesis, and methods of use thereof for prevention of organ transplantation rejection, the treatment of immune disorders and inflammation, and treatment of viral (particularly hepatitis C viral) infection.
    Type: Grant
    Filed: February 19, 2010
    Date of Patent: July 9, 2013
    Assignee: Enanta Pharmaceuticals, Inc.
    Inventors: Yat Sun Or, Guoqiang Wang, Xuri Gao, Jiang Long
  • Teaching apparatus for enterprise input-output
    Patent number: 8475169
    Abstract: A teaching apparatus for enterprise input-output includes a base, said base defining a market system; a first block body defining a management module; a plurality of bands defining a production system and a product development system module, and a business system module, each band being sandwiched between two adjacent cuboids of the first block body; a vertical column defining a planning system module; a second block body defining a strategy module; a reverse quadrangle cone defining an information processing module; a cuboid vertical column disposed at a top of the reverse quadrangle cone; and a core solid column defining an internal information system, the core solid column penetrating through a center of the first block body, the bands, the vertical column, the second block body, the reverse quadrangle cone, and the cuboid vertical column.
    Type: Grant
    Filed: February 22, 2011
    Date of Patent: July 2, 2013
    Inventor: Guoqiang Wang
  • 2'-CHLOROACETYLENYL SUBSTITUTED NUCLEOSIDE DERIVATIVES
    Publication number: 20130078217
    Abstract: The present invention relates to 2?-chloroacetylenyl-substituted nucleoside derivatives of the general formula (I): As well as pharmaceutical compositions comprising such compounds and methods to treat or prevent an HIV infection, HBV infection, HCV infection or abnormal cellular proliferation, comprising administering said compounds or compositions. In addition, the present invention includes processes for the preparation of such compounds, and the related ?-D and ?-L-nucleoside derivatives.
    Type: Application
    Filed: September 21, 2012
    Publication date: March 28, 2013
    Inventors: Guoqiang Wang, In Jong Kim, Yat Sun Or
  • METHOD AND NODE FOR ACQUIRING CONTENT AND CONTENT NETWORK
    Publication number: 20130041982
    Abstract: The present invention discloses a method and node for acquiring content and a content network, and is related to the field of communications. The method includes: receiving a content request, where the content request at least includes an identifier of requested content; determining whether the content corresponding to the identifier can be acquired locally; if yes, acquired the content corresponding to the identifier locally; otherwise, searching, according to the identifier, a name resolution system for a target node that stores the identifier, and acquiring the content corresponding to the identifier from the target node; where the name resolution system comprises a multilevel DHT and a global content resolution structure, and the global content resolution structure supports name aggregation and longest matching search.
    Type: Application
    Filed: October 16, 2012
    Publication date: February 14, 2013
    Inventors: Guangyu Shi, Guoqiang Wang, Haiyong Xie, Lingyuan Fan
  • Cyclosporin analogues for preventing or treating hepatitis C infection
    Patent number: 8367618
    Abstract: The present invention relates to cyclosporin analogues having antiviral activity against HCV and useful in the treatment of HCV infections. More particularly, the invention relates to novel cyclosporin analogue compounds, compositions containing such compounds and methods for using the same, as well as processes for making such compounds.
    Type: Grant
    Filed: January 30, 2010
    Date of Patent: February 5, 2013
    Assignee: Enanta Pharmaceuticals, Inc.
    Inventors: Yat Sun Or, Guoqiang Wang, Jiang Long, Xuri Gao
  • Cyclosporin analogues
    Patent number: 8367053
    Abstract: The present invention provides novel cyclosporin analogue compounds, pharmaceutical compositions comprising these compounds and methods of using these compounds for the treatment of disorders and diseases, including immune disorders, inflammatory disorders and viral infections.
    Type: Grant
    Filed: July 8, 2010
    Date of Patent: February 5, 2013
    Assignee: Enanta Pharmaceuticals, Inc.
    Inventors: Jiang Long, Yat Sun Or, Xuri Gao, Guoqiang Wang
  • 6,11-bridged biaryl macrolides
    Patent number: 8354383
    Abstract: The present invention discloses compounds of formula I, II or X, or pharmaceutically acceptable salts, esters, or prodrugs thereof: which exhibit antibacterial properties. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject in need of antibiotic treatment. The invention also relates to methods of treating a bacterial infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. The invention further includes process by which to make the compounds of the present invention.
    Type: Grant
    Filed: March 6, 2009
    Date of Patent: January 15, 2013
    Assignee: Enanta Pharmaceuticals, Inc.
    Inventors: In Jong Kim, Tongzhu Liu, Jiang Long, Guoqiang Wang, Yao-Ling Qiu, Heejin Kim, Yanchun Wang, Ly Tam Phan, Yat Sun Or
  • Proline substituted cyclosporin analogues
    Patent number: 8349312
    Abstract: The present invention provides novel proline substituted cyclosporinanalogue compounds, pharmaceutical compositions comprising these compounds and methods of using these compounds for the treatment of disorders and diseases, including immune disorders, inflammatory disorders and viral infections.
    Type: Grant
    Filed: July 8, 2010
    Date of Patent: January 8, 2013
    Assignee: Enanta Pharmaceuticals, Inc.
    Inventors: Guoqiang Wang, Yat Sun Or, Jiang Long, Xuri Gao
  • Method for Flexible Data Protection with Dynamically Authorized Data Receivers in a Content Network or in Cloud Storage and Content Delivery Services
    Publication number: 20120317655
    Abstract: A networking system comprising an application service that runs on a cloud infrastructure and is configured to receive dual encrypted content from a content provider and re-encrypt the dual encrypted content to enable dynamic user group control for group-based user authorization, and a cloud storage service coupled to the application service and configured to store the dual encrypted content from the content provider and the re-encrypted dual encrypted content from the application service, wherein the application service and the storage service are configured to communicate and operate with a content delivery service that uses a content delivery network (CDN) to deliver the re-encrypted content to one or more users in a group authorized by the content provider.
    Type: Application
    Filed: February 13, 2012
    Publication date: December 13, 2012
    Applicant: FUTUREWEI TECHNOLOGIES, INC.
    Inventors: Xinwen Zhang, Huijun Xiong, Guoqiang Wang
  • Method and Apparatus for Content Identifier Based Radius Constrained Cache Flooding to Enable Efficient Content Routing
    Publication number: 20120317307
    Abstract: A networking system comprising a plurality of content routers coupled to each other and to a plurality of providers and configured to route and cache content data, wherein the content routers are further configured to locate and route requested content to a user node coupled to the content routers, wherein the providers are configured to publish content and the content routers are further configured to receive and cache the content data in response to an interest request for content and to flood a content identifier for the content data to a plurality of neighboring content routers within a specified radius, wherein the content identifier enables the plurality of neighboring content routers to determine a nearest location from which to obtain the content data to enable efficient content routing.
    Type: Application
    Filed: December 6, 2011
    Publication date: December 13, 2012
    Applicant: FUTUREWEI TECHNOLOGIES, INC.
    Inventors: Ravishankar Ravindran, Guoqiang Wang, Kathleen Nichols
  • 2'ALLENE-SUBSTITUTED NUCLEOSIDE DERIVATIVES
    Publication number: 20120237480
    Abstract: The present invention relates to 2?-allene-substituted nucleoside derivatives of the general formula (I): As well as pharmaceutical compositions comprising such compounds and methods to treat or prevent an HIV infection, HBV infection, HCV infection or abnormal cellular proliferation, comprising administering said compounds or compositions. In addition, the present invention includes processes for the preparation of such compounds, and the related ?-D and ?-L-nucleoside derivatives.
    Type: Application
    Filed: March 16, 2012
    Publication date: September 20, 2012
    Inventors: YAT SUN OR, Jun Ma, Guoqiang Wang, In Jong Kim, Jiang Long, Yao-Ling Qiu
  • Method and Apparatus for a Control Plane to Manage Domain-Based Security and Mobility in an Information Centric Network
    Publication number: 20120204224
    Abstract: A networking system comprising a virtual group controller in an information centric network configured to enable mobility and security for a plurality of users groups of the information centric network, a plurality of user groups coupled to the virtual group controller and associated with the users, a plurality of agents that are each associated with one of the user groups, and a database for trusted service profile coupled to the virtual group controller, wherein the virtual group controller is configured to interact with the agents to enable mobility for the user groups using a server-less domain-based naming scheme.
    Type: Application
    Filed: January 18, 2012
    Publication date: August 9, 2012
    Applicant: Futurewei Technologies, Inc.
    Inventors: Guoqiang Wang, Xinwen Zhang, Ravi Ravindran